$36.13
-$0.02
(-0.06%)
Quote as of 4:00 PM EST on 02/14/12
Vertex Pharmaceuticals
NASDAQ:VRTX
|
$36.13
-$0.02
(-0.06%)
|
|
| Today's Open | $36.15 |
|---|---|
| Previous Close | $36.15 |
| Daily Range | $36.02 - $36.81 |
| 52-Week Range | $26.50 - $58.87 |
| Market Cap | $7.54B |
| P/E Ratio | 451.88 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 2,145,457 |
| Average Daily Volume | 3,480,372 |
| Current FY EPS | $3.12 |
VRTX Information
| Description |
|---|
| The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Label Update for Merck's Victrelis - Analyst Blog
A Look at Vertex's Intangibles
Incivek Catalyst at Play for Vertex - Analyst Blog
Curing Diseases Makes For a Bad Business Model
3rd UPDATE: Merck Swings To 4Q Profit; Sales Up 4%
4th UPDATE: Merck Swings To 4Q Profit; Sales Up 4%
3 Stocks to Get on Your Watchlist
Maximum Market: $2.9 Billion, For Now
New CEO = Dendreon Takeover Target?
